WS.I - Nanomedicine

updated on September 6, 2024


WS.I NANOMEDICINE: FROM RESEARCH TO CLINIC APPLICATION September 12
*Co-organized with:*

WORKSHOP COMMITTEE: Giovanni TOSI, Full Professor, University of Modena & Reggio Emilia, Secretary of European Technology Platform for Nanomedicine Marzia BEDONI, Head of Nanomedicine and Biophotonics Unit in Don Gnocchi Foundation
The session will deal with precision approaches for diagnosis and therapy, as well as gene therapy and drug-based RNA/DNA technologies with applications in cancer, neurological diseases, cardiovascular, rare and genetic diseases.

September 12
09:00 - 10:30 Nanomedicine: Successful Stories WS.I.1 - TT.V.J
Chairs: Giovanni TOSI, University of Modena and Reggio Emilia & Marzia BEDONI, Don Gnocchi Foundation
Research in the field of nanomedicine is continuously advancing; however, to bring real solutions into clinical practice, it is essential to align research closely with regulatory considerations, technology transfer, and ultimately, the marketing of products. In this session, international experts will explore some of the most recent and successful developments in nanomedicine research, emphasizing the significant impact that nano-products can have on clinical settings
WS.I.1.1 TT.V.J.1	Alexandre CECCALDI ETPN Current and Emerging Nanomedicine Innovations: Success Stories from the European Frontlines
WS.I.1.2 TT.V.J.2	Lorena DIEGUEZ International Iberian Nanotechnology Laboratory (INL) Nano-medical devices for liquid biopsy: our tech transfer journey
WS.I.1.3 TT.V.J.3	Francesca RE University of Milano Bicocca Patient-derived Glioblastoma Stem Cell Secretome Modulates Blood-Brain Barrier Permeability via RAGE-Dependent Signaling Pathway

11:30 - 13:00 Nanomedicine: Progresses in Nanomedicine WS.I.2 - TT.VI.K
Chairs: Giovanni TOSI, University of Modena and Reggio Emilia & Marzia BEDONI, Don Gnocchi Foundation
In this session, recent progress in nanomedicine academic research will be presented. From the initial conceptualization of nanomedicine design to the final efficacy tests, speakers will discuss the crucial step of deeply analyzing the interaction between the nano-product and the biological environment. During this session, experts will highlight the tight connection between the biological response to nano-products and their design, emphasizing how this relationship influences the effectiveness and safety of nanomedicine applications.
WS.I.2.1 TT.VI.K.1	Fabiana QUAGLIA University of Naples Italian National Center for Gene Therapy
WS.I.2.2 TT.VI.K.2	Valentina CAUDA Polytechnic University of Turin Rational Design of nanoparticles mimicking extracellular vesicles
WS.I.2.3 TT.VI.K.3	Francesca RODÀ University of Modena and Reggio Emilia & Don Gnocchi Foundation mRNA-LNP Ex Vivo Interactions with Human Whole Blood

14:00 - 15:30 Nanomedicine: Innovation WS.I.3 - TT.VII.K
Chairs: Giovanni TOSI, University of Modena and Reggio Emilia & Marzia BEDONI, Fondazione Don Gnocchi
In this session, we will explore groundbreaking advancements in technology that are revolutionizing the healthcare sector. This session will cover fundamental topics that are crucial for the progression of nanomedicine, showcasing the latest developments and key applications in treating diseases that have been notoriously difficult to manage. Speakers and experts delve into how nanotechnology is paving the way for innovative therapeutic approaches, offering new hope for conditions that have long challenged traditional medicine, shaping the future of healthcare and the role of nanomedicine in transforming patient outcomes.
WS.I.3.1 TT.VII.K.1	Sabrina CUOGHI University of Modena and Reggio Emilia Microfluidic and enzyme replacement therapy: PLGA Nanoparticles towards the development of new versatile therapeutic solutions
WS.I.3.2 TT.VII.K.2	Carlotta MARIANECCI Sapienza University of Rome Surfactant based nanobubbles: a combined strategy to enhance brain delivery
WS.I.3.3 TT.VII.K.3	Luigi CALZOLAI ISPRA, JRC European Community Advanced Characterization of Lipid-RNA therapeutics